345 EAST MAIN STREET, WARSAW, IN
Announces Second Quarter 2026 Financial Results
Files Current Report on Form 8-K to Recast Financial Information
Zimmer Biomet Holdings Enters $1.5 Billion Revolving Credit Agreement
Shareholder votes
Increases Share Repurchase Expectations — Up to $1 Billion by Year End
Announces First Quarter 2026 Financial Results
Announces Chief Financial Officer Transition
Annual Report to Security Holders
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Certificate
Registration of Securities
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Definitive Additional Information Statement
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Notice of Proposed Sale of Securities
Specialized Disclosure Report
Free Writing Prospectus